Malignant pleural mesothelioma: utility of 18 F-FDG PET.

Details

Serval ID
serval:BIB_7BC69694525B
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Malignant pleural mesothelioma: utility of 18 F-FDG PET.
Journal
Annali italiani di chirurgia
Author(s)
Spitilli M.G., Treglia G., Calcagni M.L., Giordano A.
ISSN
0003-469X (Print)
ISSN-L
0003-469X
Publication state
Published
Issued date
2007
Peer-reviewed
Oui
Volume
78
Number
5
Pages
393-396
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
Malignant Pleural Mesothelioma is a rare tumour that arise from the mesothelial cells of the pleura and in recent time the incidence of this disease is rising. Because of the implications for management and therapy, it is important to assess the accurate staging. 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG PET) is become a useful tool in the diagnosis of many neoplasms, such as Malignant Pleural Mesothelioma. In particular it has been shown to be useful in the evaluation of the extent of pleural disease, in the establishment of lymph node involvement, in the evaluation of tumour invasion into the lung and thoracic wall, in the diagnosis of extrathoracic metastases, in the assessment of the response to treatment, and in planning radiotherapy. Developments in system technology, like improvements in hybrid system (integrated Positron Emission Tomography/Computed Tomography) and the discovery of new radiopharmaceuticals, promise to make PET much more useful and versatile in the future.

Keywords
Fluorodeoxyglucose F18, Humans, Mesothelioma/diagnostic imaging, Pleural Neoplasms/diagnostic imaging, Positron-Emission Tomography, Radiopharmaceuticals
Pubmed
Create date
20/08/2017 22:23
Last modification date
03/03/2018 18:36
Usage data